Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen Reports Kras Safety Update
FDA has approved revisions to the US prescribing information for Amgen’s epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix (panitumumab). The decision follows the FDA’s December
FDA has approved revisions to the US prescribing information for Amgen’s epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix (panitumumab). The decision follows the FDA’s December
Pfizer has received European Commission (EC) approval under the EU Merger Regulation the company’s pending acquisition of Wyeth. The Commission’s decision includes Pfizer’s commitment to divest certain animal
Water Street has acquired the Pharmaceutical Development division from AAIPharma. Water Street has committed up to $75 million in equity financing to expand the business’ capabilities, with the
Essilor has announced consolidated revenue of an estimated E1.66 billion for the six months ended June 30, 2009, representing a 9.4% increase over the first half of 2008.
Takeda’s Active Pharmaceuticals Ingredient (API) manufacturing facility at Grange Castle, Clondalkin, Dublin, is now operational. The government, through IDA Ireland, supports the manufacturing facility. The facility currently employs
The European Court of Justice (ECJ) has upheld the opinion Advocate General Kokott made in March, requiring registration of reacted monomers in polymers under REACh. The court said
Danisco and Turku University are behind the first study to demonstrate that dietary supplementation with probiotic cultures may relieve the symptoms of birch pollen allergy. Reportedly, a daily
With the October deadline to re-authorize the DHS chemical plant security rules looming large, US House and Senate committees have approved budget provisions extending the rules for another
Suffolk County Superior Court allowed Pro-Pharmaceuticals’ motion to dismiss the trade secret lawsuit prosecuted by Prospect Therapeutics against the company and its former chief executive officer, David Platt.
BioCryst has reported positive results from two phase 3 studies of intravenous i.v. peramivir in patients with seasonal influenza. Shionogi conducted a three-armed, multi-center, randomized, double-blind, multi-national phase